Huawei Watch D3 pushes smartwatch blood-pressure monitoring further

Huawei's newly announced Watch D3 is attracting attention not simply as another smartwatch but because of its medical-device ambitions. The wearable has received European CE-MDR certification for ambulatory blood-pressure monitoring, strengthening Huawei's attempt to turn its Watch D family into something more clinically relevant than ordinary fitness trackers.

Conventional smartwatches increasingly offer heart-rate monitoring, ECG readings, sleep analysis and blood-oxygen measurements, but blood pressure is considerably more difficult to measure accurately from the wrist. Huawei's D series uses specialized hardware rather than relying purely on optical estimates, giving it a different physical design from conventional watches.

Medical certification does not make a consumer wearable a replacement for professional diagnosis, but it provides a stronger regulatory foundation for the feature. Huawei is betting that health monitoring will become one of the most powerful reasons for consumers to wear a device continuously. If the D3's measurements prove practical in everyday use, blood pressure could become a much larger battleground across Apple, Samsung, Google and other wearable ecosystems.